Carvedilol
Product Images NDC 70786-0142

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 70786-0142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Survival Analysis For Copernicus (intent-to-treat) (Carvedilol Fig1)

A survival analysis line graph labeled 'Survival Analysis for COPERNICUS (Intent-to-Treat)' showing % mortality on the y-axis and months on the x-axis. Two lines compare mortality rates over approximately 21 months for Carvedilol and placebo, with the Carvedilol line consistently below the placebo line, and a noted p-value of 0.004 indicating statistical significance.*

FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Fig2)

A forest plot titled 'Effects on Mortality for Subgroups in COPERNICUS' showing hazard ratios with confidence intervals for various subgroups including gender, age, race, diabetic status, ischemic status, heart rate, systolic blood pressure, and spironolactone use, with all patients included at the bottom. The x-axis represents hazard ratios from 0.0 to 2.0.*

FDA Label Image

Figure 3. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Fig3)

A survival analysis line graph comparing mortality rates over 24 months between Carvedilol and placebo groups in the CAPRICORN intent-to-treat population. The y-axis shows percentage mortality, and the x-axis displays time in months. The graph includes a P-value of 0.03 indicating statistical significance.*

FDA Label Image

Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol Fig4)

A figure titled 'Effects on Mortality for Subgroups in CAPRICORN' showing hazard ratios for various patient subgroups including age, sex, timing of randomization post-myocardial infarction, prior therapy, Killip class, thrombolytic therapy, PTCA status, heart failure history, diuretic use, angina, hypertension, diabetes, heart rate, and systolic blood pressure. Hazard ratios with confidence intervals are plotted along a horizontal axis ranging from 0.4 to 1.3, illustrating mortality risk comparisons across these categories.*

FDA Label Image

Chemical Structure (Carvedilol Str)

Chemical structure of carvedilol, showing its detailed molecular framework with functional groups and ring structures as typically depicted in pharmaceutical chemistry.*

FDA Label Image

Label Image (Lbl707860142)

Carvedilol 3.125 MG film-coated tablets in a unit dose packaging. The label indicates use in a 60 tablet package by Unit Dose Services. The label includes manufacturing information by Aurobindo Pharma Ltd, Hyderabad, India, along with storage and safety instructions. The packaging is marked RX ONLY.*

FDA Label Image

Label Image (Lbl707860144)

Carvedilol packaging label for Celecoxib 200 mg capsules, 30 count, labeled by Unit Dose Services. The label includes dosage information, storage instructions to keep at controlled room temperature (20-25°C), and warnings to keep out of reach of children. Manufacturer details indicate Micro Labs Limited, Goa, India. The label shows NDC 50436-0144-1 and includes placeholders for lot number and expiration date.*

FDA Label Image

Label Image (Lbl707860145)

Carvedilol 25 mg bottle label from Unit Dose Services. The label indicates 60 film-coated tablets, manufactured by Aurobindo Pharma Ltd in India. It includes important storage instructions, a warning to keep out of reach of children, and states the product is prescription-only (RX ONLY). The label also displays the NDC number 70786-0145-2 and batch/expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.